Monte Rosa Therapeutics Inc (GLUE)
8.92
-0.94
(-9.53%)
USD |
NASDAQ |
Dec 04, 13:54
Monte Rosa Therapeutics Price: 8.92 for Dec. 4, 2024
Price Chart
Historical Price Data
Date | Open | High | Low | Close | Volume |
---|---|---|---|---|---|
Dec 03, 2024 | 10.23 | 10.56 | 9.79 | 9.86 | 4.575M |
Dec 02, 2024 | 10.30 | 10.70 | 10.11 | 10.22 | 902004.0 |
Nov 29, 2024 | 9.23 | 10.44 | 9.23 | 10.36 | 888468.0 |
Nov 27, 2024 | 8.73 | 9.25 | 8.61 | 9.11 | 630507.0 |
Nov 26, 2024 | 8.39 | 8.99 | 8.036 | 8.60 | 911153.0 |
Nov 25, 2024 | 8.63 | 9.03 | 8.38 | 8.46 | 803538.0 |
Nov 22, 2024 | 8.36 | 8.67 | 8.24 | 8.49 | 369980.0 |
Nov 21, 2024 | 8.35 | 8.90 | 8.17 | 8.35 | 743580.0 |
Nov 20, 2024 | 8.24 | 8.62 | 8.05 | 8.36 | 736471.0 |
Nov 19, 2024 | 7.47 | 8.438 | 7.40 | 8.31 | 1.251M |
Nov 18, 2024 | 7.90 | 8.05 | 7.47 | 7.54 | 1.403M |
Nov 15, 2024 | 8.57 | 8.63 | 7.64 | 7.74 | 881291.0 |
Nov 14, 2024 | 8.72 | 8.915 | 8.38 | 8.48 | 739731.0 |
Nov 13, 2024 | 9.36 | 9.60 | 8.62 | 8.63 | 670550.0 |
Nov 12, 2024 | 9.93 | 10.22 | 9.00 | 9.13 | 1.376M |
Nov 11, 2024 | 9.50 | 10.40 | 9.320 | 10.01 | 1.727M |
Nov 08, 2024 | 9.82 | 9.85 | 9.00 | 9.26 | 793923.0 |
Nov 07, 2024 | 9.50 | 9.85 | 9.320 | 9.53 | 1.131M |
Nov 06, 2024 | 9.68 | 9.70 | 8.90 | 9.45 | 945643.0 |
Nov 05, 2024 | 8.85 | 9.37 | 8.42 | 9.36 | 688519.0 |
Nov 04, 2024 | 8.91 | 9.12 | 8.485 | 8.84 | 4.573M |
Nov 01, 2024 | 8.35 | 8.94 | 8.31 | 8.90 | 745829.0 |
Oct 31, 2024 | 9.24 | 9.54 | 8.50 | 8.50 | 1.288M |
Oct 30, 2024 | 9.47 | 9.68 | 8.91 | 9.22 | 1.850M |
Oct 29, 2024 | 9.34 | 9.52 | 8.35 | 9.37 | 5.850M |
Price Definition
The price of a security measures the cost to purchase 1 share of a security. For a company, price can be multiplied by shares outstanding to find the market capitalization (value of the company).
Price Range, Past 5 Years
2.50
Minimum
Oct 25 2023
42.21
Maximum
Sep 03 2021
10.03
Average
7.37
Median
Price Benchmarks
Novartis AG | 101.60 |
MEI Pharma Inc | 2.73 |
Evoke Pharma Inc | 4.30 |
Revance Therapeutics Inc | 4.02 |
Vera Therapeutics Inc | 49.35 |
Price Related Metrics
Price to Book Value | 2.667 |
Earnings Yield | -20.52% |
Market Cap | 548.02M |